510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Hemotec Act High Range Activated Clotting Time

K860122510(k) TraditionalCleared Apr 4, 198680-day reviewClass II21 CFR 864.7140Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medical Device Consultants, Inc. · JBP Activated Whole Blood Clotting Time

Cleared on Apr 4, 1986 after an 80-day review. FDA has not posted a summary or statement for it, so its predicates are not known. It has been recalled once.

Decided
Apr 4, 1986
Review
80 days
Class
Class II
Product code
JBP
Recalls
1
Predicates
0

FDA has not posted a summary or statement for it, so its predicates are not known.

FIG. 1 — Lineage of K860122Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JBP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JBP device

  1. #1 K223635 Sonoclot Coagulation & Platelet Function…score 4.6 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 20, 2025Class IIZ-0539-2026Under Investigation by firmMedtronic personnel observed trace amounts of dry blood on the external carton label and Instructions for Use (IFU) in five boxes of one lot of ACT Cartridges.

No ancestor or descendant has a Class I recall.

How does its category compare?

All JBP devices

JBP Activated Whole Blood Clotting Time: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JBP

1in 2023

2007: 12023: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JBP

Too few JBP 510(k)s in any year since 2007 to give a median.

Recalls per year · JBP

2in 2025

2009: 32010: 32025: 2
2007high 3 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JBP

18in 2025

2007: 52008: 62009: 292010: 242011: 112012: 252013: 322014: 32015: 262016: 42017: 162018: 12019: 152020: 102021: 92022: 72023: 162024: 232025: 18
2007high 32 (2013) · low 1 (2018)2025

MAUDE reports naming product code JBP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—05
20080—06
20090—329
20100—324
20110—011
20120—025
20130—032
20140—03
20150—026
20160—04
20170—016
20180—01
20190—015
20200—010
20210—09
20220—07
20231—016
20240—023
20250—218
20260—0—
Cite this page

510(k) Report. “K860122: Hemotec Act High Range Activated Clotting Time.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K860122

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026